Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7759882rdf:typepubmed:Citationlld:pubmed
pubmed-article:7759882lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C0879338lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C0443211lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:7759882lifeskim:mentionsumls-concept:C1514926lld:lifeskim
pubmed-article:7759882pubmed:issue12lld:pubmed
pubmed-article:7759882pubmed:dateCreated1995-6-29lld:pubmed
pubmed-article:7759882pubmed:abstractTextOur recent studies using IL-12 protein or fibroblasts genetically engineered to secrete IL-12 have demonstrated profound antitumor effects of IL-12 in murine models. The antitumor effects of local, high level IL-12 expression were examined using a retroviral vector, which can express both IL-12 subunits (p35 and p40) and the neomycin phosphotransferase (Neo)-marker gene from a polycistronic message utilizing internal ribosome entry site sequences. All animals intradermally (i.d.) receiving MCA207 murine sarcoma cell line nontransfected or Neo-transfected had progressively growing tumor, whereas all animals injected with MCA207 transfected with IL-12 were tumor free and were subsequently determined to be immune to a rechallenge of nontransfected MCA207 i.d. Similar results were obtained in experiments using the poorly immunogenic MCA102 murine sarcoma cell line. The inoculation of live MCA207-IL-12 tumor cells also caused the regression of contralateral nontransfected MCA207 inoculated either at the same time (80% protection) or up to 3 days before (33% protection) to the therapeutic tumor inoculation. In vivo depletion studies suggest that NK cells and IFN-gamma play important roles in the development of the early phase of the antitumor response, but that T cells (both CD4+ and CD8+) play the major role in the subsequent events, leading to long-term immunity. The potent antitumor effects observed for paracrine gene-delivered administration of IL-12 have thus been confirmed for multiple tumor cell types and in multiple murine strains. We believe that these results support the feasibility of IL-12 gene therapy for the treatment of human cancer.lld:pubmed
pubmed-article:7759882pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7759882pubmed:languageenglld:pubmed
pubmed-article:7759882pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7759882pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7759882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7759882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7759882pubmed:statusMEDLINElld:pubmed
pubmed-article:7759882pubmed:monthJunlld:pubmed
pubmed-article:7759882pubmed:issn0022-1767lld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:SchreiberR...lld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:TaharaHHlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:GublerUUlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:LotzeM TMTlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:ZehH JHJ3rdlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:RobbinsP DPDlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:StorkusW JWJlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:ZitvogelLLlld:pubmed
pubmed-article:7759882pubmed:authorpubmed-author:McKinleyR CRClld:pubmed
pubmed-article:7759882pubmed:issnTypePrintlld:pubmed
pubmed-article:7759882pubmed:day15lld:pubmed
pubmed-article:7759882pubmed:volume154lld:pubmed
pubmed-article:7759882pubmed:ownerNLMlld:pubmed
pubmed-article:7759882pubmed:authorsCompleteYlld:pubmed
pubmed-article:7759882pubmed:pagination6466-74lld:pubmed
pubmed-article:7759882pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:meshHeadingpubmed-meshheading:7759882-...lld:pubmed
pubmed-article:7759882pubmed:year1995lld:pubmed
pubmed-article:7759882pubmed:articleTitleEffective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.lld:pubmed
pubmed-article:7759882pubmed:affiliationDepartment of Surgery, School of Medicine, Pittsburgh Cancer Institute, University of Pittsburgh, PA 15213, USA.lld:pubmed
pubmed-article:7759882pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7759882pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7759882pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7759882lld:pubmed